Report Detail
U.S. Markets for Critical Care Patient Management Products, December 2014
Critical care in the U.S. is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Hospitals are evolving into critical care centers to which only the most seriously ill patients are admitted. Virtually every hospital unit has a significant percentage of patients benefiting from advanced technologies and equipment necessary for sustaining life, or for rapidly identifying severe clinical conditions. Increasingly, critical care is defined not so much by a designated place in the hospital—such as the ICU—but rather by the type of assessment, monitoring, nursing care, and therapy provided.
This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for critical care patient management products. Product areas covered by the scope of this report include drug and fluid delivery products (vascular access devices, infusion pumps, and gravity infusion systems), airway management and ventilation products (ventilators, manual resuscitators, anesthesia/respiratory masks, and supraglottic airways), and POC blood testing products (POC glucose analyzers, POC cardiac marker analyzers, POC blood gas analyzers, and POC coagulation analyzers).
During the forecast period covered by this report, the combined U.S. market for critical care patient management products is projected to increase from $3.9 billion in 2013 to $4.9 billion in the year 2018. Drug and fluid delivery products account for 59%, POC blood testing products account for 23%, and airway management/ventilation products account for the remaining 18%.